Logo image of CNR

CORE NATURAL RESOURCES INC (CNR) Stock Fundamental Analysis

USA - NYSE:CNR - US2189371006 - Common Stock

82.37 USD
-0.21 (-0.25%)
Last: 11/14/2025, 8:04:00 PM
82.37 USD
0 (0%)
After Hours: 11/14/2025, 8:04:00 PM
Fundamental Rating

5

CNR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 210 industry peers in the Oil, Gas & Consumable Fuels industry. CNR has an average financial health and profitability rating. While showing a medium growth rate, CNR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CNR was profitable.
In the past year CNR had a positive cash flow from operations.
Of the past 5 years CNR 4 years were profitable.
In the past 5 years CNR always reported a positive cash flow from operatings.
CNR Yearly Net Income VS EBIT VS OCF VS FCFCNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

CNR has a Return On Assets of 0.33%. This is in the lower half of the industry: CNR underperforms 68.10% of its industry peers.
CNR's Return On Equity of 0.55% is on the low side compared to the rest of the industry. CNR is outperformed by 66.67% of its industry peers.
The Return On Invested Capital of CNR (1.90%) is worse than 70.00% of its industry peers.
CNR had an Average Return On Invested Capital over the past 3 years of 24.39%. This is above the industry average of 21.72%.
The last Return On Invested Capital (1.90%) for CNR is well below the 3 year average (24.39%), which needs to be investigated, but indicates that CNR had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.33%
ROE 0.55%
ROIC 1.9%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
CNR Yearly ROA, ROE, ROICCNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

CNR's Profit Margin of 0.63% is on the low side compared to the rest of the industry. CNR is outperformed by 66.19% of its industry peers.
In the last couple of years the Profit Margin of CNR has grown nicely.
Looking at the Operating Margin, with a value of 3.73%, CNR is doing worse than 67.62% of the companies in the same industry.
CNR's Operating Margin has improved in the last couple of years.
CNR has a Gross Margin of 20.38%. This is in the lower half of the industry: CNR underperforms 65.71% of its industry peers.
CNR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.73%
PM (TTM) 0.63%
GM 20.38%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
CNR Yearly Profit, Operating, Gross MarginsCNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CNR is creating value.
CNR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CNR has been increased compared to 5 years ago.
CNR has a better debt/assets ratio than last year.
CNR Yearly Shares OutstandingCNR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CNR Yearly Total Debt VS Total AssetsCNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CNR has an Altman-Z score of 1.95. This is not the best score and indicates that CNR is in the grey zone with still only limited risk for bankruptcy at the moment.
CNR has a Altman-Z score of 1.95. This is in the better half of the industry: CNR outperforms 65.71% of its industry peers.
The Debt to FCF ratio of CNR is 2.46, which is a good value as it means it would take CNR, 2.46 years of fcf income to pay off all of its debts.
CNR has a Debt to FCF ratio of 2.46. This is in the better half of the industry: CNR outperforms 80.00% of its industry peers.
CNR has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
CNR's Debt to Equity ratio of 0.09 is fine compared to the rest of the industry. CNR outperforms 77.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.46
Altman-Z 1.95
ROIC/WACC0.22
WACC8.84%
CNR Yearly LT Debt VS Equity VS FCFCNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CNR has a Current Ratio of 1.78. This is a normal value and indicates that CNR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.78, CNR is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
CNR has a Quick Ratio of 1.25. This is a normal value and indicates that CNR is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.25, CNR is doing good in the industry, outperforming 62.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.25
CNR Yearly Current Assets VS Current LiabilitesCNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The earnings per share for CNR have decreased strongly by -94.27% in the last year.
CNR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.60% yearly.
Looking at the last year, CNR shows a very negative growth in Revenue. The Revenue has decreased by -13.20% in the last year.
The Revenue has been growing by 9.16% on average over the past years. This is quite good.
EPS 1Y (TTM)-94.27%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-81.06%
Revenue 1Y (TTM)-13.2%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%74.39%

3.2 Future

Based on estimates for the next years, CNR will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.84% on average per year.
The Revenue is expected to grow by 25.29% on average over the next years. This is a very strong growth
EPS Next Y-122.99%
EPS Next 2Y-4.05%
EPS Next 3Y2.43%
EPS Next 5Y9.84%
Revenue Next Year78.88%
Revenue Next 2Y39.25%
Revenue Next 3Y25.29%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNR Yearly Revenue VS EstimatesCNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
CNR Yearly EPS VS EstimatesCNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 105.60, the valuation of CNR can be described as expensive.
Based on the Price/Earnings ratio, CNR is valued a bit more expensive than the industry average as 68.57% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 25.89, CNR is valued quite expensively.
Based on the Price/Forward Earnings ratio of 9.31, the valuation of CNR can be described as reasonable.
CNR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CNR is cheaper than 79.52% of the companies in the same industry.
CNR is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 105.6
Fwd PE 9.31
CNR Price Earnings VS Forward Price EarningsCNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

CNR's Enterprise Value to EBITDA ratio is in line with the industry average.
CNR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 26.68
EV/EBITDA 8.04
CNR Per share dataCNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)4.67
EPS Next 2Y-4.05%
EPS Next 3Y2.43%

0

5. Dividend

5.1 Amount

With a yearly dividend of 0.48%, CNR is not a good candidate for dividend investing.
CNR's Dividend Yield is slightly below the industry average, which is at 5.87.
With a Dividend Yield of 0.48, CNR pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 0.48%

5.2 History

CNR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNR Yearly Dividends per shareCNR Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

148.79% of the earnings are spent on dividend by CNR. This is not a sustainable payout ratio.
DP148.79%
EPS Next 2Y-4.05%
EPS Next 3Y2.43%
CNR Yearly Income VS Free CF VS DividendCNR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
CNR Dividend Payout.CNR Dividend Payout, showing the Payout Ratio.CNR Dividend Payout.PayoutRetained Earnings

CORE NATURAL RESOURCES INC

NYSE:CNR (11/14/2025, 8:04:00 PM)

After market: 82.37 0 (0%)

82.37

-0.21 (-0.25%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-18 2026-02-18/bmo
Inst Owners94.28%
Inst Owner Change-2.41%
Ins Owners1.87%
Ins Owner Change-8.21%
Market Cap4.24B
Revenue(TTM)2.21B
Net Income(TTM)20.62M
Analysts82.22
Price Target114.14 (38.57%)
Short Float %6.48%
Short Ratio3.9
Dividend
Industry RankSector Rank
Dividend Yield 0.48%
Yearly Dividend0.53
Dividend Growth(5Y)N/A
DP148.79%
Div Incr Years0
Div Non Decr Years0
Ex-Date11-28 2025-11-28 (0.1)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-158.97%
Min EPS beat(2)-207.45%
Max EPS beat(2)-110.49%
EPS beat(4)1
Avg EPS beat(4)-94.7%
Min EPS beat(4)-207.45%
Max EPS beat(4)0.73%
EPS beat(8)4
Avg EPS beat(8)-35.57%
EPS beat(12)8
Avg EPS beat(12)-12.67%
EPS beat(16)10
Avg EPS beat(16)-41.07%
Revenue beat(2)2
Avg Revenue beat(2)7.34%
Min Revenue beat(2)2.77%
Max Revenue beat(2)11.91%
Revenue beat(4)3
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-24.65%
Max Revenue beat(4)11.91%
Revenue beat(8)6
Avg Revenue beat(8)1.77%
Revenue beat(12)10
Avg Revenue beat(12)5.56%
Revenue beat(16)13
Avg Revenue beat(16)9.28%
PT rev (1m)14.89%
PT rev (3m)24.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-497.92%
EPS NY rev (1m)-88.98%
EPS NY rev (3m)-139.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.17%
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)3.25%
Valuation
Industry RankSector Rank
PE 105.6
Fwd PE 9.31
P/S 1.29
P/FCF 26.68
P/OCF 10.78
P/B 1.13
P/tB 1.13
EV/EBITDA 8.04
EPS(TTM)0.78
EY0.95%
EPS(NY)8.85
Fwd EY10.74%
FCF(TTM)3.09
FCFY3.75%
OCF(TTM)7.64
OCFY9.27%
SpS63.72
BVpS73.2
TBVpS73.2
PEG (NY)N/A
PEG (5Y)4.67
Graham Number35.84
Profitability
Industry RankSector Rank
ROA 0.33%
ROE 0.55%
ROCE 2.22%
ROIC 1.9%
ROICexc 2.06%
ROICexgc 2.06%
OM 3.73%
PM (TTM) 0.63%
GM 20.38%
FCFM 4.85%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
ROICexc(3y)28.23%
ROICexc(5y)18.22%
ROICexgc(3y)28.23%
ROICexgc(5y)N/A
ROCE(3y)28.54%
ROCE(5y)18.52%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y35.93%
ROICexc growth 5Y15.67%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.46
Debt/EBITDA 0.64
Cap/Depr 58.19%
Cap/Sales 7.14%
Interest Coverage 250
Cash Conversion 74.92%
Profit Quality 770.76%
Current Ratio 1.78
Quick Ratio 1.25
Altman-Z 1.95
F-Score6
WACC8.84%
ROIC/WACC0.22
Cap/Depr(3y)74.91%
Cap/Depr(5y)64.93%
Cap/Sales(3y)7.37%
Cap/Sales(5y)8.18%
Profit Quality(3y)104.03%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.27%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-81.06%
EPS Next Y-122.99%
EPS Next 2Y-4.05%
EPS Next 3Y2.43%
EPS Next 5Y9.84%
Revenue 1Y (TTM)-13.2%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%74.39%
Revenue Next Year78.88%
Revenue Next 2Y39.25%
Revenue Next 3Y25.29%
Revenue Next 5YN/A
EBIT growth 1Y-74.63%
EBIT growth 3Y34.19%
EBIT growth 5Y12.15%
EBIT Next Year38.6%
EBIT Next 3Y35.04%
EBIT Next 5Y28.61%
FCF growth 1Y-73.9%
FCF growth 3Y19.97%
FCF growth 5Y31.85%
OCF growth 1Y-49.63%
OCF growth 3Y15.95%
OCF growth 5Y14.26%

CORE NATURAL RESOURCES INC / CNR FAQ

What is the fundamental rating for CNR stock?

ChartMill assigns a fundamental rating of 5 / 10 to CNR.


Can you provide the valuation status for CORE NATURAL RESOURCES INC?

ChartMill assigns a valuation rating of 3 / 10 to CORE NATURAL RESOURCES INC (CNR). This can be considered as Overvalued.


How profitable is CORE NATURAL RESOURCES INC (CNR) stock?

CORE NATURAL RESOURCES INC (CNR) has a profitability rating of 4 / 10.


What is the financial health of CORE NATURAL RESOURCES INC (CNR) stock?

The financial health rating of CORE NATURAL RESOURCES INC (CNR) is 6 / 10.


What is the expected EPS growth for CORE NATURAL RESOURCES INC (CNR) stock?

The Earnings per Share (EPS) of CORE NATURAL RESOURCES INC (CNR) is expected to decline by -122.99% in the next year.